Central nervous system metastases in women after multimodality therapy for high risk breast cancer

Breast Cancer Research and Treatment

Volumn 88, Issue 3, 2004, Pages 273-280

  Carey, Lisa A ^a   Ewend, Matthew G ^a   Metzger, Richard ^b   Sawyer, Lynda ^b   Dees, E Claire ^a   Sartor, Carolyn I ^a   Moore, Dominic T ^b   Graham, Mark L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Brain metastasis; Breast cancer; Central nervous system metastasis; Neoadjuvant chemotherapy; Relapse; Survival

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB; VINCA ALKALOID;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER RELAPSE; CANCER RISK; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM METASTASIS; CHEMOSENSITIVITY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TIME OF DEATH;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CENTRAL NERVOUS SYSTEM NEOPLASMS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 12344330438     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-0999-3     Document Type: Article

References (35)

1. DiStefano A, Yong Yap Y, Hortobagyi GN, Blumenschein GR: The natural history of breast cancer patients with brain metastases. Cancer 44(5): 1913-1918, 1979
2. Paterson AH, Agarwal M, Lees A, Hanson J, Szafran O: Brain metastases in breast cancer patients receiving adjuvant chemotherapy. Cancer 49(4): 651-654, 1982
3. Pierga JY, Asselain B, Jouve M, Dieras V, Carton M, Laurence V, Girre V, Beuzeboc P, Palangie T, Dorval T, Pouillart P: Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy. Cancer 91(6): 1079-1089, 2001
4. Stewart JF, King RJ, Sexton SA, Millis RR, Rubens RD, Hayward JL: Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Euro J Cancer (Oxford) 17(4): 449-453, 1981
5. Ahmann FR, Jones SE, Moon TE: The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer. J Surg Oncol 37: 116-122, 1988
6. Jones SE, Moon TE: The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer. J Sur Oncol 37(2): 116-122, 1988
7. Trudeau ME, Eisenhauer E, Dent S, Pritchard KI, Lofters W, Norris B, Muldal A, Lefendre F, Vandenberg T, Verma S: Central nervous system relapse following chemotherapy with docetaxel for metastatic breast cancer. In: Proceedings of the American Society of Clinical Oncology. 32nd Annual meeting, Philadelphia, PA, May 18-21, 1996, p. 15
8. Crivellari D, Pagani O, Veronesi A, Lombardi D, Nole F, Thurlimann B, Hess D, Borner M, Bauer J, Martinelli G, Graffeo R, Sessa C, Goldhirsch A: High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol 12: 353-356, 2001
9. Weitzen R, Zach L, Kaufman B, Tichler T, Rath P, Pfeffer R, Baram J, Ben David M, Rizel S, Catane R: High incidence of brain metastasis in patients on trastuzumab for advanced breast cancer. In: Proceedings of the American Society of Clinical Oncology. 38th Annual meeting, Orlando, FL, May 18-21, 2002, abstract #1936
10. Wardley AM, Danson S, Clayton AJ, Clemons M, Burt P, Stewart A, Waine S, Wilkinson P, Welch R, Magee B, Howell A: High incidence of brain metastases in patients treated with trastuzumab for metastatic breast cancer at a large cancer center. In: Proceedings of the American Society of Clinical Oncology. 38th Annual meeting, Orlando, FL, May 18-21, 2002, abstract #241
11. Lower EE, Blau R, Bismayer J, Brennan L, Broun R, Danneman W, Drosick DR, Hawley DK: Increased brain metastasis detected in metastatic breast cancer patients. Br Ca Res Treat 69: 357a, 2001
12. Chock JY, Domchek S, Burstein HJ, Harris L, Younger J, Kuter I, Rue M, Gelman RS, Winer ER: Central nervous system metastases in women who receive trastuzumab for metastatic breast cancer. In: Proceedings of the American Society of Clinical Oncology. 38th Annual meeting, Orlando, FL, May 18-21, 2002, abstract #218
13. Freilich RJ, Seidman AD, DeAngelis LM: Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel. Cancer 76(2): 232-236, 1995
14. Kosmas C, Malamos NA, Tsavaris NB, Stamataki M, Stefanou S, Gregoriou A, Rokana S, Vartholomeou M, Antonopoulos MJ: Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer. J Neuro-Oncol 56(3): 265-273, 2002
15. Seidman AD, Fornier MN, Esteva FJ, Tan L, Kaptain S, Bach A, Panageas KS, Arroyo C, Valero V, Currie V, Gilewski T: Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol 19(10): 2587-2595, 2001
16. Singletary ES, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Burgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RVP, Morrow M, Page DL, Recht A, Theriault RL, Hor A, Weaver DL, Wieand HS, Greene FL: Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 20: 3628-3636, 2002
17. Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M 2nd: Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann Surg 236(3): 295-302; discussion 02-3, 2002
18. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B: Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Ca Inst Monographs (30): 96-102, 2001
19. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230(1): 72-78, 1999
20. Boogerd W, Vos VW, Hart AA, Baris G: Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neuro-Oncol 15(2): 165-174, 1993
21. Kamby C, Ejlertsen B, Andersen J, Birkler NE, Rytter L, Zedeler K, Rose C: The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival. Acta Oncol 27(6A): 715-719, 1988
22. Tsukada Y, Fouad A, Pickren JW, Lane WW: Central nervous system metastasis from breast carcinoma: Autopsy study. Cancer 52(12): 2349-2354, 1983
23. Zimm S, Wampler GL, Stablein D, Hazra T, Young HF: Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48(2): 384-394, 1981
24. de la Monte SM, Hutchins GM, Moore GW: Influence of age on the metastatic behavior of breast carcinoma. Human Pathology 19(5): 529-534, 1988
25. Hagemeister FB, Buzdar AU, Luna MA, Blumenschein GR: Causes of death in breast cancer: a clinicopathologic study. Cancer 46(1): 162-167, 1980
26. Miller KD, Weathers T, Haney LG, Timmerman R, Dickler M, Shen J, Sledge GW: Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Br Ca Res Treat 69: 214a, 2001
27. Lesser GJ, Grossman SA, Eller S, Rowinsky EK: The distribution of systemically administered [3H]-paclitaxel in rats: a quantitative autoradiographic study. Cancer Chemotherapy Pharmacol 37(1-2): 173-178, 1995
28. Pestalozzi BC, Brignoli S: Trastuzumab in CSF. J Clinl Oncol 18(11): 2349-2351, 2000
29. Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E: Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97(12): 2972-2977, 2003
30. Viadana E, Cotter R, Pickren JW, Bross IDJ: An autopsy study of metastatic sites of breast cancer. Cancer Res 33: 179-181, 1973
31. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10): 2698-2705, 2002
32. Clark GM, Sledge GW, Osborne CK, McGuire WL: Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 5(1): 55-61, 1987
33. Maki DD, Grossman RI: Patterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status. Am J Neuroradiol 21(6): 1064-1066, 2000
34. Lai RK, Dang C, Thaler H, Malkin MG: The incidence of brain metastases in HER2/neu+ stage IV breast cancer patients. In: Proceedings of the American Society of Clinical Oncology. 37th Annual meeting, San Fransisco, CA, May 12-15, 2001, abstract #2014
35. Rosenberg GA: Matrix metalloproteinases in neuroinflammation. GLIA 39(3): 279-291, 2002